- Ticker
- AEHA
- Price
- 7.37
- Stock movement up
- +0.25 (3.51%)
- Company name
- Aesther Healthcare Acquisition Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Financial Services >Shell Companies
- Market cap
- 78.12M
- Ent value
- 82.89M
- Price/Sales
- -
- Price/Book
- 0.75
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -26.81%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2023-03-22
DIVIDENDS
AEHA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.75 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 10.60M |
| EPS (TTM) | -0.72 |
| FCF per share (TTM) | -0.26 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -2.39M |
| Net income (TTM) | -1.89M |
| EPS (TTM) | -0.72 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 472.11K |
| Net receivables | 0.00 |
| Total current assets | 599.61K |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 109.13M |
| Accounts payable | 181.03K |
| Short/Current long term debt | 1.05M |
| Total current liabilities | 2.09M |
| Total liabilities | 5.24M |
| Shareholder's equity | 103.89M |
| Net tangible assets | 103.89M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -690.10K |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -690.10K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -1.82% |
| Return on Assets | -1.73% |
| Return on Invested Capital | -1.80% |
| Cash Return on Invested Capital | -0.66% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 7.07 |
| Daily high | 7.47 |
| Daily low | 6.89 |
| Daily Volume | 228K |
| All-time high | 13.00 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | -0.72 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 31 May 2023 |
Downside potential
Loading...
Downside potential data
| AEHA | S&P500 | |
| Current price drop from All-time high | -43.31% | -16.50% |
| Highest price drop | -74.15% | -56.47% |
| Date of highest drop | 21 Feb 2023 | 9 Mar 2009 |
| Avg drop from high | -4.84% | -11.51% |
| Avg time to new high | 5 days | 13 days |
| Max time to new high | 119 days | 1805 days |
COMPANY DETAILS
Marketcap
78.12M
Marketcap category
Small-cap
Description
Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the pharmaceutical and medical devices sectors. The company was incorporated in 2021 and is based in New York, New York.
Employees
0
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
By Exec Edge Editorial Staff Biopharma company Ocean Biomedical (Nasdaq: OCEA) began trading publicly today after merging with a SPAC called Aesther Healthcare Acquisition Corp. (Nasdaq: AEHA). Ocean ...
February 15, 2023
Multiple Patents granted for Methods and Composition for Mono-specific and Bi-specific antibody approaches that suppress tumors by targeting and neutralizing elevated levels of chitinase 3-like-1 (CHI...
February 9, 2023
NEW YORK and PROVIDENCE, R.I, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical, Inc...
February 6, 2023
Ocean Biomedical Chairman Chirinjeev Kathuria By IPO Edge Editorial Staff Can you give me a brief description of what Ocean Biomedical does? Ocean Biomedical, which will trade on the (NASDAQ: […]
February 2, 2023
NEW YORK and PROVIDENCE, R.I., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical, Inc....
February 1, 2023
Ocean Biomedical Chairman Chrinjeev Kathuria By IPO Edge Editorial Staff Can you give me a brief description of what Ocean Biomedical does? Ocean Biomedical, which will trade on the […]
January 31, 2023
Results outline novel bispecific antibody approach that generates strong anti-tumor response in malignant melanoma, holding potential to control important pathways in multiple cancer types Ocean Biome...
January 30, 2023
Ocean Biomedical stock is expected to trade on the Nasdaq Capital Market under ticker symbol "OCEA" PROVIDENCE, RI and NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“Ocean”), a next-ge...
January 24, 2023
NEW YORK and PROVIDENCE, R.I., Jan. 13, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical, Inc....
January 13, 2023
New York, NY and Providence, RI, Dec. 16, 2022 (GLOBE NEWSWIRE) -- As previously announced, on August 31, 2022, Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) entered into definitive ...
December 16, 2022
Next page